Search Results

• September 2021: Ziad Peerwani, MD Appointed as Medical Director of Cleveland Clinic Laboratories

  Ziad Peerwani, MD has been appointed as the new Medical Director for Cleveland Clinic Laboratories, effective September 1, 2021.

• Pathology Insights – Mammary Myofibroblastoma: A Practical Approach with Miglena Komforti, DO

  Dr. Komforti discusses histopathologic findings, ancillary immunohistochemical stains, & clinical significance of mammary myofibroblastoma.

• August 2021: Changes to Specimen Requirements, Reference Ranges, and Test Builds

  All changes listed are effective August 16, 2021. Questions? Please contact Client Services at 800.628.6816.

• July 2021: Test Menu Optimization & Discontinuations – MGLESE, MYSGRV, PARSYN

  A recent review has identified tests that will be discontinued in favor of more simple, focused, and cost-effective testing options.

• July 2021: Immediate Test Discontinuation – Hepatitis A Antibody, Total (AHAVT)

  Due to vendor reagent being on backorder, AHAVT’s initially scheduled discontinuation on August 7 has been expedited to July 1, 2021.

• Pathology Insights – Diagnosis of Oncocytic Salivary Gland Tumors with Mobeen Rahman, MD

  The diagnosis of oncocytic salivary gland tumors can be challenging, especially on core needle biopsies; Dr. Mobeen Rahman discusses.

• June 2021: Send-Out Test Discontinuation – Complement Factor B (C3PA)

  This test is no longer offered by the performing reference laboratory. At this time, there is no recommended replacement test.

• CC-SIGN® Head & Neck Gene Fusion Next-Generation Sequencing Panel

  This customized, 30-gene NGS panel is intended for use in the diagnosis and management of benign and malignant tumors of the head and neck.

• Pathology Insights – NUT Carcinoma with Sanjay Mukhopadhyay, MD

  In this video, Dr. Mukhopadhyay draws attention to an immunohistochemical profile that can serve as a tip-off to the correct diagnosis.

• May 2021: Non-Sterile Aliquot Tubes – Back In Stock

  As of May 25, 2021, Sarstedt aliquot tubes are back in stock. Laboratory supply orders can be placed by clients on the Supply Storefront.

• May 2021: National Supply Shortage of Light Blue Coagulation Tubes

  There is a severe nationwide shortage of light blue sodium citrate blood collection tubes used for coagulation laboratory tests.

• Pathology Insights – Diagnosis of CD30+ T-cell Lymphoproliferative Disorders with Genevieve Crane, MD, PhD

  The diagnosis of CD30+ T-cell lymphoproliferative disorder can present challenges. In this video, Dr. Genevieve Crane discusses.

• April 2021: Changes to AIDYSA, ENCSER, PARNEO, LAMBRT, & MYGRAV Panels

  Changes listed here are effective May 11, 2021. Questions? Please contact Client Services at 800.628.6816 for assistance.

• Pathology Insights – Two Diagnoses in One Bone Marrow with Megan Nakashima, MD

  Analysis of a bone marrow requires both careful morphologic examination as well as appropriate ancillary studies; Dr. Nakashima discusses.

• Restrictions to PSA and β-HCG, Plasma Add-On Orders

  Due to a potential for falsely-increased results from carryover on analytical laboratory instrumentation, add-on orders are restricted.

• Pathology Insights – Diagnosing Microinvasive Breast Cancer with Miglena Komforti, DO

  In the breast, the pathologic diagnosis of a small focus of invasion can be quite challenging; Dr. Miglena Komforti discusses.

• February 2021: Inhibin B – Changes to Reference Ranges

  A recent change increases the detection of inhibin B in all clinically relevant cases and expands the testing range to improve sensitivity.

• Pathology Insights – Diagnosis of Metastatic Renal Cancer with Sean Williamson, MD

  Pathologic diagnosis can be challenging in the setting of poorly-differentiated and metastatic renal cancer; Dr. Williamson discusses.

• November 2020: Temporarily Unavailable – Stool Gastrointestinal Panel by PCR

  Beginning November 13, 2020, Stool Gastrointestinal Panel by PCR (STGIPR) testing is temporarily unavailable to order from CCL.

• COVID-19: Supply Constraints Affecting Enteric Bacterial Panel by PCR Testing

  Due to supply constraints related to COVID-19, supplies for Enteric Bacterial Panel by PCR (STLPCR) testing are in extremely limited supply.

• COVID-19: Unacceptable Specimen Transport Media for COVID-19 Testing

  Due to incompatibilities with our COVID-19 testing laboratory equipment, Beaver Biomedical VTM and NEST Solution are not accepted by CCL.

• COVID-19: Supply Shortages Impacting Gonorrhea, Chlamydia, and Trichomoniasis Testing

  As a result of supply shortages, Cleveland Clinic Laboratories may periodically be unable to provide Aptima® Urine Specimen Collection Tubes.

• August 2020: Update – Cytogenetic Karyotyping & Chromosomal Microarray Testing

  Starting August 24, 2020, cytogenetic karyotyping and chromosomal microarray testing will temporarily be sent out to a reference laboratory.

• August 2020: Anti-cardiolipin IgM, IgA, and IgG Reporting

  Effective 9/3/2020, Anti-cardiolipin IgM, IgA, and IgG semi-quantitative enzyme immunoassays will be reported with updated reference ranges.

• Antibody Testing for COVID-19: Overview & FAQs

  Learn more from Kamran Kadkhoda, PhD, Medical Director of Immunopathology, and Serpil Erzurum, MD, Chair of the Lerner Research Institute.

• Respiratory Virus Testing

  Cleveland Clinic Laboratories offers COVID-19, Flu, & RSV testing services to healthcare organizations & providers.

• October 2019: Changes to Specimen Requirements, Reference Ranges, and Test Builds

  Any additional information will be included in a future Technical Update. Please contact Client Services for assistance.

• Pathology Insights – Pathology of Vaping-Associated Lung Injury with Sanjay Mukhopadhyay, MD

  In this episode of Pathology Insights, Sanjay Mukhopadhyay, MD discusses the findings of a study on the lung pathology of vaping.

• September 2019: Updates to Testosterone, Free & Total, Testing and Reporting

  Any additional information will be included in a future Technical Update. Please contact Client Services for assistance.

• September 2019: Changes to Lp-PLA2 Activity Reference Ranges

  Any additional information will be included in a future Technical Update. Please contact Client Services for assistance.

• August 2019: Changes to PARNEO, FTESTO Testing

  Additional information will be included in a future Technical Update. Questions? Please contact Client Services.

• July 2019: Changes to NCYTO, URCAT2, MYOSPL, RUFIN, LIVFIB, & AJPWO Testing

  Any additional information will be included in a future Technical Update. Please contact Client Services for assistance.

• June 2019: Changes to UALDOS, TSIG, TRAB

  Any additional information will be included in a future Technical Update. Please contact Client Services for assistance.

• May 2019: Changes to Reference Ranges & Test Builds

  Any additional information will be included in a future Technical Update. Please contact Client Services for assistance.

• May 2019: Upcoming Test Changes, Updates, and Discontinuations

  Any additional information will be included in a future Technical Update. Please contact Client Services for assistance.

• March 2019: Changes to PR1433, GM1BM, OMEGAC

  Any additional information will be included in a future Technical Update. Please contact Client Services for assistance.

• March 2019: Changes to Acceptable Clobazam (CLOBAZ) Specimen Types

  Effective immediately, plasma is no longer an acceptable specimen type for Clobazam testing; serum from a gel tube remains unacceptable.

• March 2019: Changes to IgG Subclass Reference Ranges

  Effective March 2, 2019, reference ranges for IgG Subclasses 1 & 4 will be changed; all other IgG subclass reference ranges will be the same.

• CC-SIGN® NTRK Plus Gene Fusion Next-Generation Sequencing Panel

  CC-SIGN® NTRK Plus Gene Fusion NGS Panel is designed to detect fusion events in NTRK1, NTRK2, and NTRK3, regardless of fusion partner.

• CC-SIGN® Solid Tumor Gene Fusion Next-Generation Sequencing Panel

  This customized, 59-gene NGS-based panel is intended for use in the diagnosis and management of benign and malignant mesenchymal tumors.

• December 2018: Changes to RETAB, IA2AB, and PNHPNL Testing

  Any additional information will be included in a future Technical Update. Please contact Client Services for assistance.

• Pathology Insights – Pleural Fluid: Cyto-Histo Correlation by Sanjay Mukhopadhyay, MD and Charles Sturgis, MD

  A cytopathologist and a thoracic pathologist discuss their diagnostic approach on a case involving pleural fluid cytology and pleural biopsy.

• November 2018: Changes to Vitamin B12 (B12) Testing

  Any additional information will be included in a future Technical Update. Please contact Client Services for assistance.

• November 2018: Changes to Melatonin (MELAT) Testing

  Effective immediately, several changes have been made to Melatonin (MELAT), including container, collection, transport temperature.

• October 2018: Changes To COMPC1, COMP3A, & COMP4A Testing

  Effective November 5, 2018, Complement C 1 (COMPC1), Level 3A (COMP3A), Level 4A (COMP4A) will have several changes implemented.

• October 2018: Changes to ASPIGG, GAL3, HV6ABS, LIDO, & PROPA Testing

  Several upcoming changes to our test directory will affect multiple tests. Please refer to the information below for details.

• QuantiFERON-TB Gold Plus (QTB-Plus) 4-Tube Assay

  Effective September 12, CCL will convert to the QuantiFERON-TB Gold Plus (QTB-Plus) 4-Tube Assay for Mycobacterium tuberculosis testing.

• August 2018: Changes to ADRENL & RICKGM Testing

  Effective September 10, Rickettsia Antibodies IgG & IgM (RICKGM) will be discontinued. Adrenal Antibody (ADRENL) will have several changes.

• Pathology Insights – Lung Granulomas Caused by Fungal Infection with Sanjay Mukhopadhyay, MD

  Not all lung nodules are malignant. In this video, Dr. Mukhopadhyay compares two cases of lung granulomas caused by fungal infection.

• June 2018: Changes to Cyanide, Blood (CYANID) Testing

  Effective August 15, 2018, Cyanide, Blood (CYANID) will implement changes affecting transport temperature, reference ranges, and more.